Summary Apoptosis is a mode of cell death with characteristic structural features. These appear to result from a set of discrete cellular events that are regulated by gene expression. Oncogenesis and oncosuppressor genes are involved in this regulation. The role of c-myc is of particular interest, as it can act as a bivalent regulator, determining either cell proliferation or apoptosis, depending on whether free movement around the cell cycle is supported (by growth factors) or is limited by growth factor deprivation or treatment with other cycle-blocking agents. In vivo, c-myc expression may be associated with a 'high-turnover' state in which cell proliferation and apoptosis co-exist. Certain other oncogenes (e.g. ras, bcl-2) rescue cells from susceptibility to apoptosis and so convert this high-turnover state into rapid population expansion. One role of the oncosuppressor gene p53 may be to initiate apoptosis by causing G 1/S arrest in cells expressing c-myc. Some aspects of resistance and sensitivity to chemotherapeutic agents can be explained on the basis of movement between the population-expansion and the high-turnover states, perhaps through modulation of the expression of these and other genes.
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Apoptosis is a mode of cell death in which single cells are deleted in the midst of living tissue. The term derives from a Greek word used for the dropping off of leaves from trees. It is characterised by structural changes that appear with great fidelity in cells of widely different lineage, and presumably represent a pleiotropic effector response (Kerr et al., 1972; Wyllie et al., 1980; Arends & Wyllie, 1991 (Sarraf & Bowen, 1988; Moore, 1987) . Irradiation, chemotherapy and the appropriate hormone therapy all induce apoptosis in tumour cells. High doses of irradiation and chemotherapy may also cause cell destruction by other means (Searle et al., 1975; Dyson et al., 1986; Szende et al., 1989; Eastman, 1990; Lennon et al., 1990; Kyprianou et al., 1990; Kyprianou et al., 1991a,b; Martikainen et al., 1991) .
The morphological changes in apoptosis have been extensively reviewed elsewhere (Kerr et al., 1972; Wyllie et al., 1980; Kerr et al., 1987; Arends et al., 1990 condensed chromatin. Apoptotic cells do not induce an inflammatory reaction, even when present in large numbers, but they are targets of immediate phagocytosis, either by macrophages already present nearby, or by other adjacent viable cells. Within these, the compacted organelles and condensed chromatin of the apoptotic cells may be visible for a few hours but eventually reduce to large nondescript lysosomal residual bodies.
The effector mechanisms of apoptosis are still only incompletely understood. The nuclear changes are caused by activation of an endogenous calcium-magnesium sensitive nuclease (Arends et al., 1990; Wyllie, 1980) which has not yet been fully characterised. This cleaves chromatin between nucleosomes, reducing the DNA of apoptotic cells to a series of fragments, integer size multiples of 180-200 base pairs, and thus producing a characteristic 'ladder' on agarose gel electrophoresis.
The swift phagocytosis is the result of recognition by the phagocytic cell of new molecular structures revealed on the surface of the apoptotic cell. Recognition of apoptotic rodent thymocytes can be blocked in vitro by N-acetyl glucosamine and its dimer N,N'-diacetyl chitobiose, suggesting that a component of the recognition signal may be a glycan rich in exposed N-acetyl glucosamine residues (Duvall et al., 1985) . The vitronectin receptor of human macrophages is responsible for binding apoptotic human neutrophils (Savill et al., 1990) . The distinctive recognition pathway used by macrophages for binding apoptotic neutrophils may represent a control point in the physiological termination of the acute inflammatory reaction (Savill et al., 1989) .
Many apoptotic cells express a new transglutaminase activity that cross-links cytoplasmic proteins (Fesus et al., 1989; Piacentini et al., 1991; Fesus et al., 1991) . Some of the shrinkage and distortion of contour of apoptotic cells may be attributable to activation of this enzyme, but the dramatic step-like increase in buoyant density shown by cells as they enter apoptosis (Wyllie & Morris, 1982) must be due in addition to net movement of fluid out of the dying cell. A possible mechanism to account for this profound fluid shift (responsible for loss of a third to a half of cell's volume within a few minutes) is inhibition of the sodium-potassiumchloride cotransporter system (Wilcock & Hickman, 1988) .
The cellular triggers that initiate this pleiotropic response have proved elusive. Shortly before onset of the chromatin changes, at least in some cell types, free cytosolic calcium rises to sustained, but moderate levels of around 800nM (McConkeyet al., 1989a ). This appears to be important for the rest of the process, as blockade of calcium movement by pharmacological means can inhibit apoptosis. It is not known whether the sources of the calcium is external to the cell or internal (for example from mitochondria), although this might have important implications for regulation. One type of surface receptor molecule (APO-1, fas) appears to be particularly involved in the triggering of apoptosis in some cell types including leukaemic cell lines (Trauth et al., 1989; Itoh et al., 1991) . T-lymphocytes provide an example of how single receptor-ligand interactions can lead to strikingly different cellular responses. In the CD4 +, CD8 + immature cortical thymocyte, ligands that occupy the T-cell receptor initiate apoptosis, whereas in mature, post-thymic T-cells they initiate entry to S-phase . Perhaps in a similar way, TNF can trigger apoptosis in appropriate cell types (Kyprianou et al., 1991a; Laster et al., 1988) , although in other circumstances it may act as a growth factor.
In several circumstances, blockade of protein and RNA synthesis inhibits apoptosis (Wyllie et al., 1984) , but cycloheximide does not block -and indeed may initiate -apoptosis in some cell types. New transcription of genes that may be triggers for apoptosis has been sought for by a candidate gene strategy. There is a cascade-like induction of c-fos, c-myc and hsp-70 in regressing prostate, for example (Buttyan et al., 1988) , and TGFP1 is induced during regression of a hormone-sensitive breast carcinoma cell line (Kyprianou et al., 1991b) , but it is difficult from experiments of this type to be certain that the new transcripts are integral to apoptosis as opposed to other (perhaps abortive) stress responses.
Subtractive hybridisation has also been used to identify genes whose transcription is uniquely associated with apoptosis. Several candidates are now known. Regressing secretory epithelia in mammary and prostatic glands transcribe a gene coding for a highly sulphated cell surface glycoprotein with complement-inhibitory properties (TRPM-2) (Monpetit et al., 1986; Buttyan et al., 1989) , and several new transcripts appear in apoptotic lymphocytes (Owens et al., 1991) . The roles of all of these interesting new molecules have still to be established.
Regulatory genes influence cellular susceptibility to enter apoptosis. Some of these have been identified and are already familiar as oncogenes and oncosuppressor genes. At present, there are convincing data relating to c-myc, bcl-2, p53 and ras.
Expression of c-myc is of particular interest, as it seems to determine either continuous proliferation or apoptosis, depending on the availability of critical growth factors . Cultured immortalised fibroblasts respond to the addition of serum growth factors by entering the proliferation cycle, and this is preceded by and apparently dependent upon transcription of c-myc. On withdrawal of serum growth factors, c-myc is down-regulated and the cells revert to a growth-arrested state in which they may remain viable for many weeks. In cells modified to express c-myc constitutively, however, the absence of serum growth factors is not accompanied by growth arrest. Instead, the cells remain in cycle -and some may successfully complete DNA and cellular replication -whilst substantial numbers die by apoptosis. This effect of serum starvation can be produced by other interventions that blockade some step in the proliferation cycle (for example leucine deprivation, thymidineinduced S-phase arrest or treatment with topo-isomerase II inhibitor (Bertrand et al., 1991; Fanidi et al., 1992) (Dive & Wyllie, 1992) . Quantitative as well as qualitative consideration may determine cell transitions between these states.
Some cellular proto-oncogenes appear to 'rescue' cells from the high turnover state into the population expansion state. Amongst these is bcl-2 Nunez et al., 1990; Bissonnette et al., 1992; Fanidi et al., 1992 ). An elegant demonstration of this is the resistance to apoptosis of cortical thymocytes in which bcl-2 is engineered for constitutive expression (Sentman et al., 1991; Strasser et al., 1991) . Such cells fail to undergo apoptosis in response to a wide variety of stimuli to which normal thymocytes are sensitive. Activation of bcl-2 is not unique in rescuing cells from apoptosis. High expression of the mutated ras oncogenes (Wyllie et al., 1987) and exposure to many growth factors can have the same effect (Williams et al., 1990; Koury & Bondurant, 1990 ) perhaps in a cell type dependent way.
Expression of wild type p53 appears to have the opposite effect, inducing apoptosis in susceptible cells (Yonish-Rouach et al., 1991) . Wild-type p53 is known to cause temporary GI arrest in some cell types (Kastan et al., 1991) and it is thus possible that this arrest co-operates with endogenous c-myc expression to initiate apoptosis.
It is not clear how these regulatory genes influence susceptibility to apoptosis. One obvious mechanisms would be the induction or depletion of the effector proteins discussed earlier. In support of this, endogenous endonuclease activity is readily demonstrated in the nuclei of fibroblasts that constitutively express c-myc, but is absent from cells expressing mutated Ha-ras at high level (Arends, M.J.: unpublished observations) . It is convenient to designate as primed those cells in which synthesis of the effector proteins of apoptosis has been induced, and so to distinguish them both from the unprimed cells that lack effectors and cannot immediately undergo apoptosis, and from cells in the process of entering apoptosis through activation of the effectors, which we call triggered (Arends & Wyllie, 1991) . The concept that genes regulate dynamic transitions between suseptibility and resistance to apoptosis has important implications for our understanding of regulation of normal tissue kinetics and several aspects of the behaviour of tumour cells.
Thus, during affinity maturation of the immune response, virgin circulating B cells enter the follicle centre and are stimulated by local factors to rapid cell proliferation. However, the majority of these cells are destined for almost immediate death by apoptosis: they are in the high turnover state described previously complete with high c-myc expression. Only a small sub-population is selected for long-term survival (and B-cell memory) on the basis of the affinity of their surface immunoglobulin for the antigen, presented on the surface of dendritic cells in the follicle centre (Liu et al., 1989) . This 'rescue' is associated with induction of bcl-2 in the surviving cells (Nunez et al., 1991; Hockenberry et al., 1991) .
Although much less is known of the gene expression involved, an analogous situation exists in development of the nervous system. Motor neurones are generated in excess of eventual requirement, and deleted by apoptosis if their axons fail to make contact with muscle endplates, the source of growth factors which presumably rescue them from death. Rather similar processes appear to take place in the central nervous system in development of glia and the establishment of interneuronal networks in the central nervous system (Martin et al., 1988; Raff, 1992) .
One corollary of the hypotheses outlined above is that cells in the high turnover state include many that are primed for apoptosis and therefore susceptible to die by this means in response to a variety of lethal stimuli. Cells of the lymphoid follicle centre phenotype and at the base of intestinal crypts (another high-turnover, c-myc-expressing, bcl-2 expressing population) (Liu et al., 1989; Nunez et al., 1991) are indeed susceptible to apoptosis engendered by agents with widely divergent modes of action (including many used in cancer chemotherapy) (Ijiri & Potten, 1987) . There are obvious implications for toxicology and cancer chemotherapy if cell sensitivity to apoptosis can be modified by manipulation of a set of regulatory genes. Similarly, there are implications in carcinogenesis. The genes discussed above as influencing apoptosis are all familiar because of their abnormal regulation in neoplasms.
One important element in the early phases of carcinogenesis may be expansion of a target population of cells capable of subsequent genetic progression to malignancy, perhaps as a result of further genetic events. This target population may normally be kept small through apoptosis. Inappropriate rescuing stimuli may therefore be oncogenic simply because they increase the number of cells available for mutagenesis. There are several potential examples, such as ras expression in premalignant hyperplasias of breast (Going et al., 1992) and in colorectal adenomas (Williams et al., 1985) and the constitutive bcl-2 expression of follicular lymphomas and the LMP-l-induced bcl-2 expression of drug-resistant Burkitt's lymphoma cell lines (Clark et al., 1992; Gregory et al., 1991; Henderson et al., 1991) .
The pervasiveness of p53 mutation in human malignancies (Levine et al., 1991) may be accounted for in a similar way.
